| Ytd | 83.14% | |
| 1y | 87.75% |
| Open | 83.58 | Prev Close | 83.00 | Low | 81.72 | High | 86.66 | Mkt Cap | 6.58B |
| Vol | 1.84M | Avg Vol | 1.72M | EPS | -8.92 | P/E | N/A | Forward P/E | 24.56 |
| Beta | N/A | Short Ratio | 3.40 | Inst. Own | 108.43% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 58.77 | 200-d Avg | 48.63 | 1yr Est | 82.07 |
HNGE News
Hinge Health Inc. (HNGE) saw its shares surge in the last session with trading volume being higher t
Wells Fargo analyst Stan Berenshteyn maintains Hinge Health (NYSE:HNGE) with a Overweight and rai
Baird analyst Vikram Kesavabhotla maintains Hinge Health (NYSE:HNGE) with a Neutral and raises th
Raymond James analyst Brian Peterson maintains Hinge Health (NYSE:HNGE) with a Outperform and rai
Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises
Keybanc analyst Scott Schoenhaus maintains Hinge Health (NYSE:HNGE) with a Overweight and raises
RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:HNGE) with a Outperform and raises
Truist Securities analyst Jailendra Singh maintains Hinge Health (NYSE:HNGE) with a Buy and raise
Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the
Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price
Hinge Health, Inc. (NYSE:HNGE) announced today its full year 2026 revenue guidance raised to a range
Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises